(Q54042038)

24 May 2018

title

Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas. (English)

1 reference

24 May 2018

1 reference

Mayr D

1

1 reference

24 May 2018

Pannekamp U

2

1 reference

24 May 2018

Baretton GB

3

1 reference

24 May 2018

Gropp M

4

1 reference

24 May 2018

Meier W

5

1 reference

24 May 2018

Flens MJ

6

1 reference

24 May 2018

Scheper R

7

1 reference

24 May 2018

Diebold J

8

1 reference

24 May 2018

publication date

1 January 2000

1 reference

24 May 2018

Pathology, Research and Practice

published in

1 reference

24 May 2018

volume

196

1 reference

24 May 2018

issue

7

1 reference

24 May 2018

page(s)

469-475

1 reference

24 May 2018

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Anti-proliferative activity and mechanism of action of titanocene dichloride

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Chemotherapy resistance in ovarian cancer: new molecular perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overview

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

New platinum antitumor complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) expression in ovarian carcinomas. Correlation with clinicopathology and sex steroid receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

p53 gene mutations and protein accumulation in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

The drug resistance-related protein LRP is the human major vault protein

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2800%2980048-5

7 January 2021

10.1016/S0344-0338(00)80048-5

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018